Join
Live feed
·
PRReleasevia Quantisnow
BioMarin Pharmaceutical Inc. logo

BioMarin Announces Appointment of Robert Plenge, M.D., Ph.D., Chief Research Officer of Bristol Myers Squibb, to Board of Directors

ByQuantisnow·Wall Street's wire, on your screen.
BMRN· BioMarin Pharmaceutical Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track BMRN (BioMarin Pharmaceutical Inc.) and more on Quantisnow.